Genetics of Lipid Lowering Drugs and Diet Network | NHLBI Trans-Omics for Precision Medicine Skip to main content

Genetics of Lipid Lowering Drugs and Diet Network

Short Name
GOLDN
Institution(s)
University of Alabama
Type of Omics
WGS
Approx. Sample Size 967
Disease/Phenotype
Lipids, omics, dietary intervention
Starting Phase
Phase 2
TOPMed Accession #
phs001359
Omics Center(s) Phase 2
Northwest Genomics Center
Phases Involved
2
Populations
European families
PI
Contact
NIH Program Officer
Phenotype Liaison
Data Set contact(s)
Project
GOLDN
Back to top